[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.211.168.204. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Citations 0
Capitol Health Call
February 13, 2008

e-Prescribing Barrier

JAMA. 2008;299(6):625. doi:10.1001/jama.299.6.625-c

The US Drug Enforcement Administration's (DEA’s) reluctance to approve regulations covering the electronic prescribing of controlled substances is costing the country billions in health care savings each year, said Sen Sheldon Whitehouse (D, RI). This heel dragging is also causing unnecessary adverse drug events, which occur more often with patients who receive their medications via a handwritten prescription, said Whitehouse, who chaired a December hearing on the issue by the Senate Judiciary Committee.

First Page Preview View Large
First page PDF preview
First page PDF preview
×